254 results on '"Sin, Don D"'
Search Results
2. Best in Class: IgG as a Treatable Trait for Exacerbation Prevention in Chronic Obstructive Pulmonary Disease.
3. What Harm Are We Doing to Our Patients with Asthma by Using High-Dose Inhaled Corticosteroids?
4. Normative Reference Equations for Breathlessness Intensity during Incremental Cardiopulmonary Cycle Exercise Testing
5. Leveraging Computed Tomography Imaging to Detect Chronic Obstructive Pulmonary Disease and Concomitant Chronic Diseases.
6. A Cost-Effectiveness Analysis of Azithromycin for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
7. Why Is Body Mass Index Related to Chronic Obstructive Pulmonary Disease? Is It All in the Genes?
8. Phenotypes, Etiotypes, and Endotypes of Exacerbations of Chronic Obstructive Pulmonary Disease
9. Blood Gene Expression and Immune Cell Subtypes Associated with COPD Exacerbations
10. Blood-based Transcriptomic and Proteomic Biomarkers of Emphysema.
11. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
12. Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision
13. Blood Gene Expression and Immune Cell Subtypes Associated with Chronic Obstructive Pulmonary Disease Exacerbations.
14. Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement
15. Airway Aging and Methylation Disruptions in HIV-associated Chronic Obstructive Pulmonary Disease
16. Ambient Air Pollution and Dysanapsis: Associations with Lung Function and Chronic Obstructive Pulmonary Disease in the Canadian Cohort Obstructive Lung Disease Study
17. Development of a Blood-based Transcriptional Risk Score for Chronic Obstructive Pulmonary Disease
18. Computed Tomography Vascular Tree-in-Bud: A Novel Prognostic Imaging Biomarker in COVID-19?
19. Effects of Inhaled Corticosteroid/Long-Acting β2-Agonist Combination on the Airway Microbiome of Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Clinical Trial (DISARM)
20. Personal Interventions for Reducing Exposure and Risk for Outdoor Air Pollution: An Official American Thoracic Society Workshop Report
21. IgG Levels and Mortality in Chronic Obstructive Pulmonary Disease
22. Clotting in COVID-19: Is It All in the Genes?
23. Airway Aging and Methylation Disruptions in HIV-associated Chronic Obstructive Pulmonary Disease.
24. Predicting Severe Chronic Obstructive Pulmonary Disease Exacerbations. Developing a Population Surveillance Approach with Administrative Data
25. Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline
26. Computed Tomography Total Airway Count Is Associated with the Number of Micro–Computed Tomography Terminal Bronchioles
27. Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis
28. Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline
29. Supplementary Appendix to "Development of A Blood-Based Transcriptional Risk Score for Chronic Obstructive Pulmonary Disease".
30. Effects of Inhaled Corticosteroid/Long-Acting β2-Agonist Combination on the Airway Microbiome of Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Clinical Trial (DISARM).
31. Sputum Microbiome Is Associated with 1-Year Mortality after Chronic Obstructive Pulmonary Disease Hospitalizations
32. Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee
33. Current Status and Future Opportunities in Lung Precision Medicine Research with a Focus on Biomarkers. An American Thoracic Society/National Heart, Lung, and Blood Institute Research Statement
34. Underdiagnosis and Overdiagnosis of Chronic Obstructive Pulmonary Disease
35. Pulmonary Vascular Involvement in Chronic Obstructive Pulmonary Disease. Is There a Pulmonary Vascular Phenotype?
36. Chronic Obstructive Pulmonary Disease as a Risk Factor for Cardiovascular Disease. A View from the SUMMIT
37. Global Initiative for Chronic Obstructive Lung Disease 2017 Classification and Lung Function Decline in Chronic Obstructive Pulmonary Disease
38. Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study
39. Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study
40. Integrative Genomics of Emphysema-Associated Genes Reveals Potential Disease Biomarkers
41. Diagnostic Instability and Reversals of Chronic Obstructive Pulmonary Disease Diagnosis in Individuals with Mild to Moderate Airflow Obstruction
42. American Thoracic Society/National Heart, Lung, and Blood Institute Asthma–Chronic Obstructive Pulmonary Disease Overlap Workshop Report
43. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
44. Clotting in COVID-19: Is It All in the Genes?
45. The Projected Epidemic of Chronic Obstructive Pulmonary Disease Hospitalizations over the Next 15 Years. A Population-based Perspective
46. Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care
47. Sex Differences in Airway Remodeling in a Mouse Model of Chronic Obstructive Pulmonary Disease
48. Chronic Obstructive Pulmonary Disease and Stroke. Strange Bedfellows
49. Airway Epithelial Expression Quantitative Trait Loci Reveal Genes Underlying Asthma and Other Airway Diseases
50. Novel genes for airway wall thickness identified with combined genome-wide association and expression analyses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.